20-F: Elbit Systems Reports Strong 2025 Growth, Record Backlog

Sentiment:

Annual Report


Elbit Systems announced robust financial results for 2025, driven by significant contract wins and strategic expansions, despite ongoing geopolitical challenges.

Delay expectedSupply chain disruptions and failures of suppliers to comply with requirements or laws sometimes result in added costs and manufacturing delays.Increased delays and stringency in obtaining export authorizations and other approvals from certain foreign governments have caused delays in receiving items and supply chain disruptions, exacerbated by the Swords of Iron war.Delays in adopting Israeli government budgets have negatively impacted the IMOD's ability to adopt new budgets, enter into new programs, and make timely payments to suppliers.The company's evacuation date for its Ramat HaSharon facility in Israel has been extended several times, with the most recent extension until the end of 2026.
Capital raiseOn May 23, 2025, the company closed an offering of 1,570,267 ordinary shares at a price of $375 per share, for total gross proceeds of approximately $588 million.In September 2023, the company filed a shelf prospectus with the Israeli Securities Authority and the TASE, which was extended in September 2025, providing a framework to raise funds through various debt and equity securities.On May 21, 2025, a Registration Statement on Form F-3 was filed with the SEC, allowing for the offering and sale of ordinary shares, warrants, debt securities, guarantees, purchase contracts, units, or any combination thereof.
Better than expectedConsolidated revenues increased by 16.3% to $7,938.6 million in 2025, indicating strong growth.Gross profit margin improved to 24.4% in 2025 from 24.0% in 2024.Operating income increased significantly to $671.4 million (8.5% of revenues) in 2025 from $489.1 million (7.2% of revenues) in 2024.Net income attributable to shareholders rose to $534.3 million (6.7% of revenues) in 2025 from $321.1 million (4.7% of revenues) in 2024.Diluted EPS increased to $11.39 in 2025 from $7.18 in 2024.Backlog of orders grew to $28,131 million as of December 31, 2025, from $22,617 million in 2024, demonstrating strong future revenue potential.The effective tax rate decreased to 9.9% in 2025 from 11.4% in 2024, contributing to higher net income.Dividend per share increased to $2.45 in 2025 from $2.00 in prior years, reflecting improved financial health.

Summary

  • Consolidated revenues for 2025 increased by 16.3% to $7,938.6 million, up from $6,827.9 million in 2024.
  • Gross profit for 2025 was $1,935.3 million, representing 24.4% of revenues, an increase from 24.0% in 2024.
  • Operating income rose to $671.4 million (8.5% of revenues) in 2025, compared to $489.1 million (7.2% of revenues) in 2024.
  • Net income attributable to shareholders reached $534.3 million (6.7% of revenues) in 2025, a significant increase from $321.1 million (4.7% of revenues) in 2024.
  • Diluted earnings per share (EPS) for 2025 was $11.39, up from $7.18 in 2024.
  • The backlog of orders as of December 31, 2025, grew to $28,131 million, with 72% for international orders, compared to $22,617 million in 2024.
  • Net research and development (R&D) expenses were $517.1 million (6.5% of revenues) in 2025, slightly down from 6.8% in 2024.
  • Key contracts awarded in 2025 included a $1.6 billion defense solution contract for a European country and a $2.3 billion international strategic solution contract.
  • The company made strategic CAPEX investments and expanded operations in Europe (Sweden, Germany) and the U.S., with new production sites in Israel becoming operational.
  • A public offering of 1,570,267 ordinary shares in May 2025 generated approximately $588 million in gross proceeds.
  • The effective tax rate decreased to 9.9% in 2025 from 11.4% in 2024, primarily due to valuation allowance releases and tax settlements.
  • Dividends paid increased to $2.45 per share in 2025, up from $2.00 per share in 2024 and 2023.
  • Net cash flow provided by operating activities was approximately $778 million in 2025, driven by increased advances from customers.
  • Working capital stood at $1,758 million with a current ratio of 1.29 as of December 31, 2025.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance driven by increased global defense spending and strategic execution, despite geopolitical challenges. The significant growth in revenue, net income, and backlog, coupled with strategic investments and a lower effective tax rate, indicates robust operational health and future potential.

Positives

  • Consolidated revenues increased by 16.3% year-over-year to $7,938.6 million in 2025, demonstrating strong top-line growth.
  • Gross profit margin improved to 24.4% in 2025 from 24.0% in 2024, indicating enhanced operational efficiency.
  • Operating income saw a substantial increase to $671.4 million (8.5% of revenues) in 2025 from $489.1 million (7.2% of revenues) in 2024.
  • Net income attributable to shareholders grew significantly to $534.3 million (6.7% of revenues) in 2025 from $321.1 million (4.7% of revenues) in 2024.
  • Diluted EPS increased to $11.39 in 2025 from $7.18 in 2024, reflecting improved profitability on a per-share basis.
  • The backlog of orders reached a record $28,131 million as of December 31, 2025, providing strong revenue visibility for future periods.
  • Significant contract awards in 2025, including a $1.6 billion contract for a European country and a $2.3 billion international strategic solution, highlight strong market demand and competitive positioning.
  • Strategic CAPEX investments and global expansion, including new facilities in Sweden, Germany, and the U.S., enhance local delivery capabilities and customer support.
  • Increased integration of AI, robotics, and advanced analytics into manufacturing facilities is improving operational efficiency and supporting growth.
  • Financial expenses, net, decreased to $138.6 million in 2025 from $151.1 million in 2024, mainly due to lower interest expenses and reduced debt levels.
  • The effective tax rate decreased to 9.9% in 2025, benefiting from valuation allowance releases and tax settlements.
  • The company increased its quarterly dividend payments to $2.45 per share in 2025, signaling confidence in financial performance.

Negatives

  • Geopolitical conflicts in the Middle East and between Russia and Ukraine have caused supply chain and operational constraints, including increased transportation costs, material/component shortages, and elevated prices.
  • The company has experienced increased delays and stringency in obtaining export authorizations from certain foreign governments, impacting supply chain and deliveries.
  • Employee call-ups for military reserve duty in Israel, affecting approximately 8% of the workforce as of March 5, 2026, have caused program delays and incurred uncompensated labor costs.
  • A reluctance from certain countries to purchase from Israeli companies and attacks on some of the company's global facilities by anti-Israel organizations have been observed since October 7, 2023.
  • Increased dependency on single sources of supply for certain materials poses a risk to production continuity.
  • The company faces risks from rapid technological changes and increased competition from deep-tech and non-traditional defense contractors, which may develop disruptive technologies faster and offer lower prices.
  • The company is subject to an internal investigation by the NATO Support and Procurement Agency (NSPA) and a temporary suspension from participating in new tenders, extended until March 2026, though the company did not identify irregularities.
  • The company's evacuation date for its Ramat HaSharon facility in Israel has been extended multiple times, with the most recent extension until the end of 2026, indicating potential delays in facility transitions.

Risks

  • Cyber or security attacks, including sophisticated nation-state attacks and those using AI, could lead to breaches, disruptions, IP theft, or operational failures.
  • Supply chain disruptions, single-source dependencies, and component obsolescence, exacerbated by global geopolitical conditions (e.g., Russia-Ukraine conflict, Houthi attacks in Red Sea), could cause manufacturing delays and increased costs.
  • Inability to recruit and retain key employees, particularly those with specialized training and security clearances, is a risk, intensified by military reserve duty call-ups in Israel.
  • Operational and execution risks exist due to increased demand and rapid expansion, potentially leading to failure in fulfilling contracts on schedule or achieving desired returns on investment.
  • Acquisitions and investments carry risks such as failure to identify material risks during due diligence, negative impact on financial results, goodwill impairment, unanticipated costs, and challenges in integration.
  • Malfunctions, undetected problems, or misuse of products could lead to substantial repair/replacement costs, liability claims, and reputational damage.
  • Labor relations disputes or failure to amend collective bargaining agreements in a timely manner could result in labor disputes, slowdowns, or strikes.
  • Climate change, evolving Environmental, Social, and Governance (ESG) regulatory requirements, and market responses could increase operational costs, lead to legal proceedings, or affect reputation.
  • Dependence on government business means revenues are subject to governmental budgetary constraints, changes in priorities, or reductions in security assistance (e.g., U.S. FMF to Israel).
  • International operations expose the company to risks from geopolitical deterioration, trade sanctions, tariffs, and protests against Israel or the company.
  • Increasing requirements for industrial participation and localization by customers may involve complex operational issues, investments, and potential contractual penalties for non-compliance.
  • Risks associated with Artificial Intelligence (AI) technologies include significant resource investment, competitive disadvantage, evolving legal frameworks, increased liability, IP issues, data privacy concerns, and potential for errors or bias.
  • Competition with certain potential customers (prime contractors pursuing vertical integration) could reduce the addressable market.
  • Contracts may be terminated, amended, or delayed by customers for various reasons, including convenience, potentially affecting revenue and profit.
  • Participation in competitively awarded contracts is complex, costly, and time-consuming, with risks of inaccurate pricing proposals and bid protests.
  • Currency exchange risks, particularly from NIS appreciation against the U.S. dollar or Euro depreciation, can negatively impact costs and revenues, with hedging not fully protecting against sharp fluctuations.
  • Increased levels of inflation and interest rates could significantly raise employee wages, CPI-linked expenses, and borrowing costs, and impact customer purchasing power.
  • Fixed-price contracts carry the risk of cost overruns, which could reduce profits or generate losses.
  • Pre-contract costs may not be recoverable if anticipated contracts are not awarded or sales levels are insufficient.
  • Fluctuations in revenues and profit margins can occur due to changes in pricing, sales volume, project mix, and cumulative catch-up adjustments in percentage-of-completion accounting.
  • Backlog of projects is subject to unexpected adjustments, delays in payments, and cancellations.
  • Debt obligations include covenants that, if breached, could lead to acceleration of debts and other penalties.
  • Inherent limitations of internal control systems may lead to financial reporting errors or fraud.
  • Financing risks include difficulties in arranging or providing guarantees for customer financing, exposure to customer credit risks, and delays in payments.
  • Effective tax rate may fluctuate due to changes in revenue mix, tax laws (e.g., OECD BEPS/Pillar 2), and tax assessments.
  • Classification as a Passive Foreign Investment Company (PFIC) could result in adverse U.S. federal income tax consequences for U.S. shareholders.
  • Tariffs and trade tensions could adversely affect economic conditions and increase operational costs.
  • Funding obligations to pension plans are impacted by financial market performance and interest rates, potentially reducing liquidity.
  • Business risks may not be adequately covered by insurance, especially for new technologies or exclusions like war and terror.
  • Compliance with government procurement and anti-bribery/corruption rules is critical, with non-compliance leading to penalties or debarment.
  • Israeli Defense Entities Law, if applied, could limit the ability of potential purchasers to acquire significant interest in the company and impose other restrictions on operations.

Future Outlook

The company anticipates continued material increases in demand for its products and solutions from the Israel Ministry of Defense and global governments, driven by elevated geopolitical tensions and plans for increased defense spending worldwide. The focus is on advanced capabilities for high-intensity conflicts, including C4ISR systems, cyber-defense, AI, autonomous systems, and precision munitions. The company believes its core technologies and global presence position it to benefit from these market trends, though the full impact of ongoing conflicts remains difficult to predict.

Management Comments

  • Management believes the U.S. dollar is the primary currency of the economic environment in which the company operates.
  • Management believes that the financial institutions holding the company's investments have a high credit rating.
  • Management believes that the company and its Israeli subsidiaries met all conditions of the Law for the Encouragement of Capital Investments and letters of approval.
  • Management believes that Elbit Systems and certain of its Israeli subsidiaries meet the conditions and qualify for the Special Preferred Technological Enterprise tax regime.
  • Management believes that the company has adequate sources of funds to meet its material commitments for capital expenditures for the fiscal year ending December 31, 2025, and the subsequent fiscal year.

Industry Context

StockSavvy.ai notes that the global defense industry is experiencing a significant upswing in demand, fueled by escalating geopolitical tensions in Eastern Europe, the Middle East, and Asia-Pacific. This shift is driving increased defense spending and a focus on advanced capabilities for high-intensity conflicts, including C4ISR, cyber-defense, AI, autonomous systems, and precision munitions. Elbit Systems, with its diverse portfolio and expanding global footprint, is well-positioned to capitalize on these trends, aligning with the growing emphasis on local manufacturing capabilities and supply chain independence, as evidenced by the IMOD's 'Blue and White' strategy.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chair of the BoardMichael FedermannDavid FedermannAugust 2023David Federmann previously served as Vice Chair of the Board since 2015.
Executive Vice President Airborne Electro-Optic Systems Business Line & Regional Business DevelopmentNASasson Meshar2025Appointment to a new executive role, previously Vice President and Senior Vice President in the ISTAR division.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board PolicyThe Board adopted a policy to include a minimum of two directors with financial and accounting expertise.NAEnhances financial oversight and expertise on the Board.
Director Term ExtensionProf. Ehood (Udi) Nisan's term as an independent director was extended for an additional one-year period beyond the nine-year limit, approved by shareholders in October 2025.October 2025Retains valuable expertise and unique contribution to the Board and its committees, as determined by the audit committee and the board.
D&O Liability InsuranceThe Compensation Committee approved the extension of the D&O liability insurance policy in July 2025, covering all Office Holders, including Michael Federmann, David Federmann, and Bezhalel Machlis.July 2025Ensures continued protection for directors and officers against liabilities, consistent with the company's Compensation Policy and Israeli regulations.
Insider Trading PolicyThe company adopted an updated Insider Trading Policy, with Section 16(a) reporting requirements for directors and officers becoming effective March 18, 2026.March 18, 2026Strengthens compliance with insider trading laws and regulations, promoting ethical conduct and transparency in securities transactions.
Equity Incentive Plan ApprovalThe company follows Israeli home country practice, which does not require shareholder approval for the establishment or material amendment of equity-based compensation plans (2018 Equity Plan and 2022 Equity Incentive Plan), in lieu of Nasdaq Rule 5635(c).NAAllows for more flexible and efficient approval of equity compensation plans, but may afford less protection to investors compared to U.S. domestic issuers under Nasdaq rules.
Shareholder Meeting QuorumThe company's Articles of Association provide for a 10% quorum requirement for adjourned shareholder meetings, consistent with Israeli law, which differs from Nasdaq Rule 5620(c)'s one-third requirement.NAFacilitates the conduct of adjourned shareholder meetings by requiring a lower quorum, but may differ from U.S. corporate governance norms.

Legal Proceedings

  • In July 2025, the NATO Support and Procurement Agency (NSPA) notified the company and two of its subsidiaries of an internal investigation and a temporary suspension from participating in new tenders, which was extended until March 2026. The company did not identify any irregularities or non-compliance.

Related Party Transactions

  • The company engages in transactions with related parties, including companies affiliated with Federmann Enterprises Ltd. (FEL), for goods and services such as materials, systems, hotel services, and catering.
  • Sales to related-party companies amounted to $155,126 thousand in 2025.
  • Supplies from related parties amounted to $39,707 thousand in 2025.
  • Trade receivables and other receivables from related parties totaled $183,649 thousand as of December 31, 2025.
  • Trade payables and advances to related parties totaled $48,556 thousand as of December 31, 2025.
  • Loans to related parties amounted to $1,541 thousand as of December 31, 2025, including a $1,500 thousand loan to a 49%-owned affiliate bearing a 5% annual interest rate.
  • The company does not believe its related party transactions are material or unusual in nature or conditions.

Stakeholder Impact

  • Shareholders: Benefited from increased dividends ($2.45 per share in 2025) and a successful share offering, but face potential risks related to PFIC classification for U.S. shareholders and the significant influence of the major shareholder (FEL).
  • Employees: Experienced increased demand for products leading to recruitment, but also faced challenges from military reserve duty call-ups (affecting up to 8% of Israeli workforce) which resulted in uncompensated labor costs. Equity incentive plans aim to link compensation with company success.
  • Customers (Governments): Showed increased demand for products and solutions, particularly from the IMOD, but also imposed increasing industrial participation requirements and stringent export controls, potentially affecting delivery timelines.
  • Suppliers: Faced supply chain disruptions, increased costs, and in some cases, cybersecurity incidents, leading to increased inventory holdings by the company to mitigate risks.
  • Creditors: The company maintained material compliance with its loan obligations and repaid significant amounts of commercial paper and notes, indicating sound financial management of debt.

Next Steps

  • Gradual increase in production at the new munitions production site in Ramat Beka during 2026 and thereafter.
  • Continued efforts to reduce supply chain disruptions, including increasing inventories and optimizing inventory planning.
  • Active pursuit of developing local capabilities in major markets, including subsidiaries with significant manufacturing capacity and organic supply chains in the U.S. and Europe.
  • Analyzing the potential impact of the new OECD Pillar 2 rules on consolidated financial statements.
  • The Israeli government is anticipated to initiate the formal process for approvals required under the Israeli Defense Entities Law and issue a control and acquisition permit to existing controlling shareholders.
  • Ongoing efforts to optimize the Enterprise Resource Planning (ERP) ecosystem and add more capabilities.
  • The Board of Directors will hold cybersecurity discussions on a semi-annual basis.
  • The internal auditor will annually examine risk-related aspects of the company's cybersecurity controls.
  • Management has adopted a multi-year cybersecurity work plan, which is formulated in coordination with cybersecurity professionals and approved annually.

Key Dates

DateDescription
2018-02-27Board of Directors adopted the 2018 Equity Incentive Plan for Executive Officers.
2021-02-01Board of Directors amended the 2018 Equity Incentive Plan (First Amendment).
2022-01-16Board of Directors adopted the 2022 Equity Incentive Plan for Employees.
2023-10-07Hamas terrorists infiltrated Israel, commencing the Swords of Iron war.
2024-02-091832 Asset Management L.P. filed Schedule 13G, reporting ownership of less than 5% of ordinary shares.
2024-02-14Clal Insurance Enterprises Holdings Ltd. filed Schedule 13G, reporting ownership of less than 5% of ordinary shares.
2024-02-15Board of Directors amended the 2018 Equity Incentive Plan (Second Amendment).
2024-02Board approved an increase of the 2022 Equity Incentive Plan option pool to 2,050,000 options.
2024-02-29Elbit Systems United Kingdom sold its wholly-owned subsidiary, Elite KL Ltd.
2024-09Company completed an issuance in Israel of a U.S. Dollar denominated commercial paper series B.
2024-10S&P Global downgraded Israel's long-term credit rating from A+ to A.
2024-11Ceasefire agreed to between Israel and Lebanon involving the conflict with Hezbollah.
2025-01Ceasefire agreed to between Israel and Hamas.
2025-02-15Board of Directors amended the 2018 Equity Incentive Plan (Second Amendment).
2025-05-21Elbit Systems filed a Registration Statement on Form F-3 with the SEC, which became automatically effective.
2025-05-23Company closed an offering of 1,570,267 ordinary shares at $375 per share.
2025-06Ceasefire declared between Israel and Iran.
2025-07FASB issued ASU 2025-05, effective December 15, 2025.
2025-07-10Compensation Committee approved the extension of the D&O liability insurance policy.
2025-08Israeli Knesset amended the Privacy Protection Law, 5741-1981, which came into force.
2025-09One of the company's suppliers experienced a cybersecurity incident.
2025-09Shelf prospectus with the Israeli Securities Authority and TASE was extended for an additional year.
2025-09FASB issued ASU 2025-06, effective December 15, 2027.
2025-10Subsequent ceasefire with Hamas was agreed to.
2025-10Shareholders reappointed Kost Forer Gabbay & Kasierer as independent auditors.
2025-10Shareholders approved the extension of Prof. Nisan's term of office for an additional one-year period.
2025-11FASB issued ASU 2025-09, effective for fiscal years beginning after December 15, 2026.
2025-11-15S&P Global upgraded Israel's long-term credit rating to A with a stable outlook.
2025-11-17Board of Directors approved the Third Amendment to the 2018 Equity Incentive Plan, extending the expiration date of options granted on or after this date to 63 months.
2025-11-17Board of Directors approved the First Amendment to the 2022 Equity Incentive Plan, extending the expiration date of options granted on or after this date to 63 months.
2025-12FASB issued ASU 2025-12 (Codification Improvements), which the company early adopted.
2025-12FASB issued ASU 2025-11, effective for fiscal years beginning after December 15, 2027.
2025-12FASB issued ASU 2025-10, effective for fiscal years beginning after December 15, 2028.
2025-12-17C4I and Cyber sold its holdings in Robo-Team Holdings Ltd.
2025-12-31Fiscal year ended.
2025-12-31Company completed the acquisition of the remaining 49% equity interest in a U.K. Subsidiary.
2026-01-01Israeli local minimum tax for multinational enterprise groups became effective.
2026-02Company fully repaid the Series A commercial paper.
2026-02-28Israel and the U.S. launched a joint attack on Iran named Operation Roaring Lion by Israel and Operation Epic Fury by the U.S.
2026-03-02Hezbollah launched an attack on Israel.
2026-03-05Date of share ownership information and approximately 8% of Israel workforce called up for reserve duty.
2026-03-17Filing date of the annual report on Form 20-F.
2026-03-18Section 16(a) reporting requirements for directors and officers became effective.
2026-12-31Most recent extension for the company's evacuation date for its Ramat HaSharon facility in Israel.

Recommendation

strong buy

Elbit Systems' 2025 performance demonstrates exceptional financial strength and strategic execution, with significant increases in revenue, net income, and diluted EPS. The record-high backlog of $28.1 billion provides substantial revenue visibility and indicates robust future growth potential, particularly in a global environment of increased defense spending. Strategic investments in R&D, global expansion, and operational efficiencies, including AI integration, position the company favorably against evolving market demands. While geopolitical risks and supply chain challenges are present, the company's ability to navigate these complexities and deliver strong results, coupled with a rising dividend, suggests a compelling investment opportunity for long-term growth.

Keywords

Elbit Systems, Defense Technology, Aerospace, C4I, Cyber Defense, ISTAR, Electronic Warfare, Land Systems, Munitions, Unmanned Aircraft Systems, Artificial Intelligence, SEC Filing, Annual Report, Financial Performance, Backlog, Israel Ministry of Defense, U.S. Government Contracts, Global Defense Spending, Supply Chain Management, Equity Incentive Plans, Dividends, Corporate Governance, Risk Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.